Find a Doctor

Dr. Cyriel Y Ponsioen

Academic Medical Center

Bio


Cyriel Ponsioen is in Amsterdam, Netherlands. Dr. Ponsioen is a global expert in Sclerosing Cholangitis. They have been an author on 183 peer reviewed articles and participated in 2 clinical trials in the past 15 years. In particular, they have been an author on 52 peer reviewed articles and participated in 2 clinical trials regarding Sclerosing Cholangitis.

Contact

Amsterdam, NH, NL

Latest Advances


  • Condition: Terminal Ileitis in Crohn's Disease
  • Journal: The lancet. Gastroenterology & hepatology
  • Treatment Used: Laparoscopic Ileocaecal Resection or Infliximab
  • Number of Patients: 143
  • Published —
This study compared the clinical outcome of using a laparoscopic ileocaecal resection or infliximab to treat patients with terminal ileitis in Crohn's disease.
  • Condition: Primary Sclerosing Cholangitis (PSC)
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Tumor Necrosis Factor (TNF) Antagonists
  • Number of Patients: 141
  • Published —
This study evaluated the effects of tumor necrosis factor (TNF) antagonists (medicines that suppress the body's natural response to tumor necrosis factor, a protein produced by white blood cells that is involved in early inflammatory events) in patients with primary sclerosing cholangitis (chronic disease in which the bile ducts inside and outside the liver become inflamed and scarred, and eventually narrowed or blocked; PSC).
  • Condition: Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Vedolizumab
  • Number of Patients: 102
  • Published —
The study researched the outcomes of Vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases.
  • Condition: Primary Biliary Cholangitis
  • Journal: Journal of hepatology
  • Treatment Used: Ursodeoxycholic Acid Therapy
  • Number of Patients: 3902
  • Published —
In this study, researchers evaluated the outcomes of treating primary biliary cholangitis with ursodeoxycholic acid therapy.
  • Condition: Primary Sclerosing Cholangitis
  • Journal: Gastroenterology
  • Treatment Used: Stents versus balloon dilatation
  • Number of Patients: 65
  • Published —
This study compared the efficacy and safety of balloon dilatation versus short-term stents in patients with primary sclerosing cholangitis.
  • Condition: Crohn's disease/Terminal ileitis
  • Journal: The lancet. Gastroenterology & hepatology
  • Treatment Used: Laparoscopic ileocaecal resection versus infliximab
  • Number of Patients: 143
  • Published —
This study compared the effects of laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease.

Clinical Trials


Clinical Trial
  • Status: Recruiting
  • Intervention Type: Device
  • Participants: 105
  • Start Date: December 6, 2018
Cholangioscopy in Primary Sclerosing Cholangitis (PSC)
Clinical Trial
  • Status: Unknown status
  • Phase: Phase 3
  • Intervention Type: Procedure
  • Participants: 100
  • Start Date: May 2011
Multicenter Randomized Trial Comparing Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis

All Publications
View All


Contact

Amsterdam, NH, NL

Insurance

Contact them to find out if they accept your insurance plan.